Parallel Advisors »

Virpax Pharmaceuticals shares owned by Parallel Advisors

Quarter-by-quarter ownership of Virpax Pharmaceuticals shares owned by Parallel Advisors from 13F filings

Historical chart of Parallel Advisors investment in Virpax Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Virpax Pharmaceuticals held by Parallel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Virpax Pharmaceuticals by Parallel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $4 14 0.36

More positions owned by Parallel Advisors

Ishares Core S&p Total U.s. Stock Market Etf Etf (ITOT)
Ishares S&p 500 Index Etf (IVV)
Apple Stock (AAPL)
Corcept Therapeutics Stock (CORT)
Ishares Msci Usa Quality Factor Etf Etf (QUAL)
Microsoft Stock (MSFT)
Cvb Finl Corp Stock (CVBF)
Nvidia Corp Stock (NVDA)
Ishares Core Msci Eafe Etf Etf (IEFA)
Vanguard Large Cap Etf (VV)
Amazon.com Stock (AMZN)
Ishares Tr Lehman Short Trea Bd Etf (SHV)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Ishares Aggregate Bond Etf Etf (AGG)
Vanguard Small Cap Etf Etf (VB)

View all positions for Parallel Advisors

Top funds holding Virpax Pharmaceuticals

Pnc Financial Services
Vanguard Group
Sheets Smith Wealth Management
Two Sigma Securities
UBS Group
Jpmorgan Chase & Co
Advisor Group Holdings
Wells Fargo & Company
Parallel Advisors

View all funds holding Virpax Pharmaceuticals